Sensory gating deficit assessed by the P50 midlatency auditory evoked potential in untreated patients with Alzheimer’s Disease (AD): correlation with NeuroPsychiatric Symptoms (NPS) and modifications induced by the Cholinesterase Inhibitor (CHEI) done